Pharmaceutical agents for the treatment of myocardial...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/405 (2006.01) A61K 31/40 (2006.01) A61K 31/41 (2006.01) A61K 31/44 (2006.01) A61K 31/495 (2006.01)

Patent

CA 2143544

This invention relates to the use of certain 3- substituted 2-oxindole-1-carboxamides of the formula: Image (I) (wherein X is H, halogen, alkyl, alkoxy, alkylthio, CF3, alkylsulfonyl, nitro, phenyl, alkanoyl, benzoyl, thenoyl, alkanamido, benzamido or dialkylsulfamoyl; Y is H, halogen, alkyl, cycloalkyl, alkoxy, alkylthio or CF3, or X and Y, together with carbon atoms to which they are attached, form a ring, R1 is alkyl, cycloalkyl, cycloalkenyl, optionally substituted phenyl, optionally substituted phenylalkyl, optionally substituted phenoxyalkyl, thiophenoxyalkyl, naphthyl, etc. n is 0, 1 or 2, Q is a divalent cyclic radical, and R ? is H, halogen or alkyl) and their pharmaceutically acceptable base salts for the treatment or prevention of ischemia induced myocardial injury and cytokine mediated myocardial injury in mammals, including humans.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical agents for the treatment of myocardial... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical agents for the treatment of myocardial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical agents for the treatment of myocardial... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1774764

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.